These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 3042335)
1. Atherogenicity of insulin. Martin DB Diabetes Res Clin Pract; 1988; 4 Suppl 1():58-61. PubMed ID: 3042335 [No Abstract] [Full Text] [Related]
2. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A; Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645 [TBL] [Abstract][Full Text] [Related]
3. Poor glycaemic control and retinopathy in non-insulin-dependent diabetes mellitus. Bastyr EJ; Janes J; Barnett AH Diabet Med; 1997 Nov; 14(11):993-4. PubMed ID: 9400930 [No Abstract] [Full Text] [Related]
4. Hypoglycemia--mechanisms and prevention in NIDDM treatment with insulin. Zahnd GR Diabetes Res Clin Pract; 1988; 4 Suppl 1():62-5. PubMed ID: 3042337 [No Abstract] [Full Text] [Related]
5. [Insulin secretion and aging. Implications for insulin therapy in the geriatric patient with diabetes mellitus]. Fritsche A; Stumvoll M; Häring HU Med Klin (Munich); 2003 Apr; 98(5):287-91. PubMed ID: 12721675 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI. Malmberg KA; Efendic S; Rydén LE Diabetes Care; 1994 Sep; 17(9):1007-14. PubMed ID: 7988298 [TBL] [Abstract][Full Text] [Related]
7. Localized insulin allergy treated with continuous subcutaneous insulin. Pratt EJ; Miles P; Kerr D Diabet Med; 2001 Jun; 18(6):515-6. PubMed ID: 11472474 [No Abstract] [Full Text] [Related]
8. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication]. Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A; Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220 [TBL] [Abstract][Full Text] [Related]
9. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies. Malmberg K; Rydén L Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029 [TBL] [Abstract][Full Text] [Related]
10. Early insulin: an important therapeutic strategy. Dailey GE Diabetes Care; 2005 Jan; 28(1):220-1. PubMed ID: 15616256 [No Abstract] [Full Text] [Related]
11. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L; Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614 [TBL] [Abstract][Full Text] [Related]
12. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Genuth S Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200 [TBL] [Abstract][Full Text] [Related]
13. [Should insulin treatment be avoided? Blood sugar is not everything in type 2 diabetes]. Carlsen SM Tidsskr Nor Laegeforen; 1995 Aug; 115(18):2271-5. PubMed ID: 7652727 [TBL] [Abstract][Full Text] [Related]